Skip to Main Content

Paper Details

Efficacy Outcomes of Brolucizumab Versus Aflibercept in Neovascular Age-Related Macular Degeneration Patients with Early Residual Fluid.
Ophthalmol Retina
3
2022
Author NameAffiliation
Rishi P SinghCenter for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Richard GaleYork Teaching Hospital, University of York
Giovanni StaurenghiUniversity Eye Clinic
  • 1 - 3

Datasets

Release 1.2